Oxford Immunotec
Oxford Immunotec Signs up Green Cross Medical Science to Market T-Cell SARS-CoV-2 Kit in South Korea
Oxford Immunotec's T-SPOT Discovery SARS-CoV-2 kit adds a research test for measuring the T cell response to SARS-CoV-2 infection to GCMS' portfolio.
PerkinElmer to Buy Oxford Immunotec for $591M
The deal will enable PerkinElmer to grow its infectious disease testing portfolio to include latent tuberculosis detection, it said.
UK researchers said they are developing a commercial test that could enable sensitive detection of tuberculosis DNA in blood and provide an option to broaden screening.
The Ticks and Mosquitoes Will Get You
The CDC says that the number of people in the US who have been infected with diseases carried by mosquitoes, ticks, and flea bites have more than tripled in recent years.